Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
09 07 2020
09 07 2020
Historique:
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
18
7
2020
Statut:
ppublish
Résumé
The emergence of SARS-CoV-2 has driven a global research effort to identify medical countermeasures at an unprecedented pace. In this issue of Cell, Cao et al. identify thousands of SARS-CoV-2 neutralizing antibodies from convalescent donors. The authors improve our understanding of immunity against the coronavirus spike glycoprotein and detail novel pathways to rapidly identify and characterize protective monoclonal antibodies.
Identifiants
pubmed: 32649880
pii: S0092-8674(20)30748-0
doi: 10.1016/j.cell.2020.06.017
pmc: PMC7346785
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-9Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
Science. 2020 Aug 7;369(6504):650-655
pubmed: 32571838
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Immunol Rev. 2016 Mar;270(1):65-77
pubmed: 26864105
Cell. 2016 Jul 28;166(3):609-623
pubmed: 27453470
Am J Pathol. 2020 Aug;190(8):1680-1690
pubmed: 32473109
Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
J Virol. 2018 Apr 27;92(10):
pubmed: 29514901